Pimecrolimus Cream, 1%
Sponsors
Actavis Inc., Glenmark Pharmaceuticals Ltd. India, Mylan Inc., Pfizer
Conditions
Atopic Dermatitis
Phase 3
Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis
CompletedNCT02791308
Start: 2015-02-28End: 2016-07-31Updated: 2020-05-29
Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis
CompletedNCT02896101
Start: 2016-08-31End: 2017-06-30Updated: 2019-07-31
Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis
CompletedNCT03107611
Start: 2016-02-29End: 2017-05-15Updated: 2022-03-07